Group B Streptococcal disease remains a leading cause of sepsis and meningitis in young infants. In the ISSAD Epidemiology track, renowned speakers from across the globe showcase the long-term outcome data in GBS survivors from low/middle- and high-income countries. The track includes analysing multicentre, cross-cutting high-quality data estimates of neurodevelopmental impairment and the cost implications of nursing children surviving GBS during infancy. In addition, speakers address the paucity of data on the burden of GBS-associated preterm and stillbirths and propose epidemiological constructs to overcome the data gaps, particularly in Africa, where the burden remains the highest.
| Convener: Prof. Joy Lawn & Prof. Ziyaad Dangor |
| Intro: Prof. Joy Lawn (5 min) |
| GBS long term outcomes including NDI: |
| S1: Dr. Merijn W Bijlsma (8 min) Title: Danish and Dutch findings |
| S2: Dr. Proma Paul (8 min) Title: Low and Middle-Income Countries Cohort findings |
| Questions and Voting (10 min) |
| GBS associated perinatal outcomes |
| S3: Dr. Anna Seale (8 min) Title: GBS and Preterm |
| S4: Dr. Quique Bassat (8 min) Title: GBS and Stillbirths |
| S5: Dr. Erzsébet Horváth-Puhó (8 min) Title: Maternal Outcomes |
| Discussion (5 min) |
| S6: Linde Snoek (5 min) Title: Prematurity modifies the risk of long-term neurodevelopmental impairments after GBS infections |
| S7: Dr. Justina Barmugy (5 min) Title: Insights on GBS disease in Mozambican infants: two decades of morbidity and mortality surveillance |
| S8: Panel Discussion, Voting and Conclusion (15 min) |